ARCHIVES

NCI’s Goal To Increase Minority Participation In Trials, Sondik Says

This article is from The Cancer Letter archive.

Vol. 21 No. 18 | May 5, 1995

Download PDF Visit The Full Archive

Related Articles

Celgene Signs CRADA With NCI For Development Of CDC-501.

June 30, 2000

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

March 21, 2003

Abeloff Plans To Step Down As Cancer Center Director at Hopkins.

November 10, 2006

In Brief: Broder Keynote Speaker At ACCC Meeting; Tefft To Head Radiation Therapy At Cleveland Clinic

February 24, 1989

Poverty Play Key Role In Excess Cancer Deaths Among Minorities, President’s Cancer Panel Hears

July 26, 1991

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014